INTERNATIONAL VITAMIN CORP
10-C, 1996-05-10
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: TEMPLETON GLOBAL INVESTMENT TRUST, PRES14A, 1996-05-10
Next: INTERNATIONAL VITAMIN CORP, SC 13D, 1996-05-10




                                                   ---------------------------
                                                           OMB APPROVAL
                                                   ---------------------------
                                                       OMB Number: 3235-0191
                                                    Expires: November 30, 1996
                                                     Estimated average burden
                                                    hours per response....0.20
                                                   ----------------------------
                                                          
                                                          
                                   UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION   
                               Washington, D.C. 20549         
                                                              

                                      Form 10-C

                   REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
                            INTERDEALER QUOTATION SYSTEM

    Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
                        and Rule 13a-17 or 15d-17 thereunder

                                  IVC INDUSTRIES, INC.
- - --------------------------------------------------------------------------------
                  (Exact name of issuer as specified in charter)

           500 Halls Mill Road, Freehold, New Jersey 07728
- - --------------------------------------------------------------------------------
                       (Address of principal executive offices)

                                  
  Issuer's telephone number, including area code ( 908 ) 308-3000
                                                 ----------------


                    I. CHANGE IN NUMBER OF SHARES OUTSTANDING

Indicate any change (increase or decrease) of 5% or more in the number of 
shares outstanding:

1. Title of security Common Stock
                    ------------------------------------------------------------
2. Number of shares outstanding before the change   13,257,379
                                                   -----------------------------
3. Number of shares outstanding after the change   17,078,742
                                                   -----------------------------
4. Effective date of change April 30, 1996
                            ----------------------------------------------------
5. Method of change:
   Specify method (such as merger, acquisition, exchange, distribution,
   stock split, reverse split, acquisition of stock for treasury, etc.)
        merger
   -----------------------------------------------------------------------------
   Give brief description of transaction Merger of Hall Laboratories,
                                        ----------------------------------------
   Inc., an Oregon corporation, with and into the Issuer with the
  ------------------------------------------------------------------------------
   Issuer as the surviving corporation.
  ------------------------------------------------------------------------------

                     II. CHANGE IN NAME OF ISSUER

   1. Name prior to change
                            ----------------------------------------------------
   2. Name after change
                         -------------------------------------------------------
   3. Effective date of charter amendment changing name 
                                                        ------------------------
   4. Date of shareholder approval of change, if required
                                                          ----------------------

Date  May 8, 1996                           /s/ Arthur S. Edell, President
      -------------------------------     --------------------------------------
                                              (Officer's signature & title)





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission